Back to Search
Start Over
Dienogest reduces endometrioma volume and endometriosis-related pain symptoms
- Source :
- Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 41(8)
- Publication Year :
- 2021
-
Abstract
- This study aimed to evaluate the efficacy and adverse effects of dienogest for the treatment of endometriomas. Dienogest (2 mg/day) was administered to patients with endometrioma continuously through the 6-month study period. The patients were prospectively examined on the efficacy and side effects at baseline, at third months, and sixth months of the treatment. Twenty-four out of 30 patients were able to complete the study. The mean volume of the endometrioma decreased significantly from 112.63 ± 161.31 cm³ at baseline to 65.47 ± 95.69 cm³ at a 6-month follow-up (-41%) (
- Subjects :
- Adult
medicine.medical_specialty
Visual analogue scale
Endometriosis
Urology
Pelvic Pain
Contraceptives, Oral, Hormonal
03 medical and health sciences
chemistry.chemical_compound
Endometrium
0302 clinical medicine
medicine
Humans
Nandrolone
Prospective Studies
Adverse effect
Menstruation Disturbances
Pain symptoms
Pain Measurement
Uterine Diseases
030219 obstetrics & reproductive medicine
business.industry
Obstetrics and Gynecology
Organ Size
medicine.disease
Treatment Outcome
Dienogest
chemistry
030220 oncology & carcinogenesis
Female
business
Subjects
Details
- ISSN :
- 13646893
- Volume :
- 41
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
- Accession number :
- edsair.doi.dedup.....e837d859704e54349eb6bc82d0036fae